ENDO ONE targets multi-zone facial rejuvenation for aesthetic clinics

ENDO ONE SRL is pitching a diode endolaser platform for jawline, mid-face and under-eye treatments as aesthetic clinics see rising demand for minimally invasive facial lifting with less downtime. The company says the system is designed for outpatient use, precise subdermal energy delivery and natural-looking results across several facial zones.

Why it matters: - Aesthetic clinics are seeing more demand for facial rejuvenation that lifts tissue without incisional surgery or long recovery. - ENDO ONE is positioning its platform for patients who want structural improvement with minimal downtime and natural-looking outcomes. - The system is designed to address several aging patterns at once, including skin laxity, descending fat compartments and dermal thinning.

What happened: - ENDO ONE SRL, based in Pozzuoli, Italy, introduced the ENDO ONE platform for professional facial rejuvenation in aesthetic clinics. - The company says the diode endolaser system is engineered for multi-zone facial treatments across the lower face, mid-face and periorbital region. - The platform is intended for outpatient procedures using local tumescent anesthesia. - The company directs clinics to the official website for technical specifications, clinical resources and partnership inquiries.

The details: - The platform delivers controlled photothermal energy into subcutaneous tissue planes. - ENDO ONE says practitioners can use the system to target localized tissue laxity, elevate descended fat pads and smooth fine lines in a single session. - Subdermal application uses minute entry points and flexible optical micro-fibers to reach targeted tissue layers. - The system is meant to support immediate collagen contraction and longer-term neocollagenesis. - In the mid-face, the company describes fan-shaped fiber placement from the lateral zygomatic arch toward the medial nasolabial fold. - In the jawline and lower face, the platform is designed to address pre-jowl fat and fibrous bands while redefining the cervicofacial angle. - In the under-eye area, ENDO ONE says 400-micrometer fibers support conservative energy delivery through the thin infraorbital plane. - The system uses a 650 nanometer aiming beam for direct visual guidance during placement. - The company says six hundred micrometer fibers are suited to mid-face and mandibular contouring, while 400 micrometer fibers are better for thin periorbital skin and fine lines. - Adjustable red aiming beam controls allow operators to verify subdermal positioning and switch between continuous and pulsed modes. - ENDO ONE says clinicians can monitor tissue temperature with tactile feedback and non-contact infrared thermal sensors. - The company says epidermal surface temperatures should stay below 40 to 42 degrees Celsius.

Between the lines: - ENDO ONE is framing the platform as a surgical alternative for clinics that want to offer lifting without rhytidectomy. - The pitch leans on precision, anatomy-specific fiber selection and same-day treatment workflows, which are key selling points in the aesthetics market. - The company is also emphasizing safety controls, likely to reassure clinics about treating thinner and more delicate facial zones.

What's next: - Clinics can request platform specifications, procedural guidelines and onboarding consultation through the company’s portal. - ENDO ONE is aiming to help practices standardize multi-zone facial protocols and shorten room turnaround times. - The company expects the system to support broader adoption among patients seeking visible tightening with brief recovery periods.

The bottom line: - ENDO ONE is betting that aesthetic clinics will pay for a device that promises targeted facial lifting across the jawline, mid-face and under-eye area with limited downtime and no incisions.